Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03935425
Other study ID # 1R44HD097803-01
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 29, 2021
Est. completion date December 31, 2022

Study information

Verified date March 2024
Source Flint Rehabilitation Devices, LLC
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators will investigate the efficacy of a newly developed functional exercise device (FitMi Plus) for people in the chronic stage after a stroke compared to the FitMi Basic (i.e. without functional exercises). FitMi Plus combines objects commonly used during activities of daily living with sensors that can track and record the patient's direction and degree of movement as they perform specific functional tasks described on a computer.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date December 31, 2022
Est. primary completion date October 31, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria: - Experienced 1 or more strokes >6 months prior to enrollment - Upper Extremity Fugl-Meyer Score >=15 and <=55 out of 66 - Absence of moderate to severe upper extremity pain (<= 4 out of 10 on the visual-analog pain scale) - Ability to understand the instructions to operate FitMi products Exclusion Criteria: - Lack of concurrent severe medical problems - Lack of visual deficits - Lack of severe neglect or apraxia - No concurrent enrollment in another therapy study

Study Design


Related Conditions & MeSH terms


Intervention

Device:
FitMi Plus
A set of common objects that couple with a wireless sensor platform to allow the performance of functional exercises to be measured by a motivating software platform.
FitMi Basic
A wireless sensor platform that allows movement subcomponents and point-to-point exercises to be measured by a motivating software platform.

Locations

Country Name City State
United States Rancho Research Institute, Inc Downey California
United States Human Neuroperformance Laboratory at University of California Irvine Irvine California

Sponsors (3)

Lead Sponsor Collaborator
Flint Rehabilitation Devices, LLC Rancho Research Institute, Inc., University of California, Irvine

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Motor Activity Log A self-reported measure of the quality of movement and amount of use of the impaired upper extremity across a set of activities of daily living. Minimum value = 0, maximum value = 5, higher scores = better outcome Baseline and One-Month Post-Treatment, at seven weeks
Secondary Change in Upper Extremity Fugl-Meyer A standardized assessment of arm impairment based on scores of 0-2 on 33 different tasks. Minimum value = 0, maximum value = 66, higher scores = better outcome Baseline and One-Month Post-Treatment, at seven weeks
See also
  Status Clinical Trial Phase
Completed NCT03281590 - Stroke and Cerebrovascular Diseases Registry
Recruiting NCT03685578 - CERENOVUS Neurothrombectomy Devices Registry
Recruiting NCT05591183 - CERENOVUS Neurothrombectomy Devices Registry
Completed NCT04465019 - Exoskeleton Rehabilitation on TBI
Completed NCT02827825 - Patients Undergoing Strokes Admitted in Intensive Care Requiring Neurosurgical ICU Crossing: Patient Profile and Prognosis
Recruiting NCT02077582 - Longitudinal MRI Examinations of Patients With Brain Ischemia and Blood Brain Barrier Permeability N/A
Terminated NCT01705353 - The Role of HMGB-1 in Chronic Stroke N/A
Completed NCT01732679 - Sunnaas International Network´s Stroke Study N/A
Completed NCT01182818 - Fabry and Stroke Epidemiological Protocol (FASEP): Risk Factors In Ischemic Stroke Patients With Fabry Disease N/A
Completed NCT00311025 - Stroke: Reduction of Physical Performance Post Stroke. Inactivity or Secondary Complications? Phase 1/Phase 2
Withdrawn NCT03804125 - A Study of Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement Surgery
Completed NCT05435404 - Qualitative Study Patient & Physician Experiences Botox COVID-19
Completed NCT03898960 - Post Marketing Study to Evaluate the NIMBUS Device
Not yet recruiting NCT06087094 - A Trial of HRS-7450 in Chinese Healthy Volunteers Phase 1
Completed NCT02207023 - Healthy Lifestyles After Stroke - Stroke Coach N/A
Active, not recruiting NCT02017574 - Motor Learning in Stroke Phase 0
Completed NCT02002390 - Efficacy and Safety of FTY720 for Acute Stroke Phase 2
Completed NCT01864382 - "Core Stability" Exercises to Improve Sitting Balance in Stroke Patients N/A
Recruiting NCT04447599 - Conjunctival and Retinal Vascularization and Small Vessel Disease N/A
Recruiting NCT04157179 - Cerebral Oxygen Metabolism in Children N/A